๐ฐ First Wealth News
Page 3 - First Wealth News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from First Wealth. Real-time updates on events, politics, business and more.
February 13, 2024
AI can improve compliance systems but, given the existence of cyber criminals, human oversight remains crucial
December 19, 2023
Itโs been another busy year in financial advice world. So little time seems to have passed since I wrote my leader about how 2022 was the โyear of the consolidatorโ.
August 25, 2023
Catch up on Money Marketing's most popular stories this week. Tenet to offload ARs to Openwork and Primis following strategic review and Canada Life reports record-breaking annuity sales.
August 24, 2023
A trio of former First Wealth financial planners have decided to set up their own advice firm - Finova Money โ which will focus on serving the next generation of clients.
August 24, 2023
Good morning and welcome to your Morning Briefing for Thursday 24 August 2023. To get this in your inbox every morning click here. New advice business launches A trio of former First Wealth financial planners - Scott Millar, Rob Schwarz and Rob Bell - have set up their own advice firm called Finova Money. The firm
August 2, 2023
Putting profits back into a business is a common way to grow it and increase its value. But given the cost of running a business has increased, it is arguably more important than ever to choose what to reinvest in wisely.
June 21, 2023
In recent years, there has been a growing recognition of the importance of diversity and inclusivity (D&I) in the workplace and financial services is not immune to the shift. As Pride month continues, Sahar Nazir delves into the initiatives and practices put in place by financial advisory firms to support their LGBTQ+ employees...
June 15, 2023
National Chartered wealth management firm Progeny has achieved B Corp certification.
April 30, 2023
Sitting on large amounts of cash is rarely the answer, so do this instead
April 27, 2023
Safe Formulations Pvt Ltd registered with Pharmexcil in 2008 as a small-scale manufacturer. Pharmexcil has asked the company to furnish the details of licensees, procurers, manufacturing license copies and product permissions of the drug by 27 April, failing which its registration will be suspended, said Pharmexcil director general Uday Bhasker.